2025年1-10月，废弃资源综合利用业企业数（以下数据涉及的企业，均为规模以上工业企业，从2011年 起，规模以上工业企业起点标准由原来的年主营业务收入500万元提高到年主营业务收入2000万元）为 4162个，和上年同期相比，增加了350个，同比增长9.18%，占工业总企业的比重为0.8%。 上市公司：格林美（002340），惠城环保（300779），神雾节能（000820），法尔胜（000890），盈峰 环境（000967），楚环科技（001336）龙净环保（600388），菲达环保（600526），宇通重工 （600817），景津装备（603279） 相关报告：智研咨询发布的《2026-2032年中国废弃资源综合利用行业市场研究分析及投资机会研判报 告》 2016-2025年1-10月废弃资源综合利用业企业数统计图 数据来源：国家统计局，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 ...

上市公司：格林美（002340），惠城环保（300779），神雾节能（000820），法尔胜（000890），盈峰 环境（000967），楚环科技（001336）龙净环保（600388），菲达环保（600526），宇通重工 （600817），景津装备（603279） 2019年-2025年1-10月全国废弃资源综合利用业出口货值统计图 数据来源：国家统计局，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 相关报告：智研咨询发布的《2026-2032年中国废弃资源综合利用行业市场研究分析及投资机会研判报 告》 根据国家统计局数据可知：2025年10月全国废弃资源综合利用业出口货值为7.3亿元，同比增长55%； 2025年1-10月全国废弃资源综合利用业累计出口货值为74亿元，累计同比增长53.7%。 ...

Core Viewpoint - The report highlights the growth of the waste resource utilization industry in China, indicating a significant increase in the number of enterprises and their contribution to the industrial sector [1]. Industry Summary - As of January to September 2025, the number of enterprises in the waste resource utilization industry reached 4,144, an increase of 373 enterprises compared to the same period last year, representing a year-on-year growth of 9.89% [1]. - The waste resource utilization enterprises accounted for 0.79% of the total industrial enterprises [1]. Company Summary - The report mentions several companies involved in the waste resource utilization sector, including Greenme (002340), Huicheng Environmental Protection (300779), Shenwu Energy Saving (000820), and others [1]. - These companies are part of a growing industry that is expected to see continued investment opportunities as highlighted in the market research report by Zhiyan Consulting [1].

Group 1 - The core point of the news is that Fengbei Biotechnology experienced a significant stock price increase of 172.60% on November 5, with a trading volume of 1.65 billion yuan [1] - As of November 5, the company had a total financing balance of 37.91 million yuan, which represents 1.83% of its market capitalization [1] - The company reported a revenue of 2.251 billion yuan for the period from January to September 2025, reflecting a year-on-year growth of 62.32% [2] Group 2 - The company was established on July 25, 2014, and is primarily engaged in the comprehensive utilization of waste oil resources, with a significant portion of its revenue coming from bio-based materials [1] - The number of shareholders for Fengbei Biotechnology reached 55,500 as of November 5, marking an increase of 792,357.14% compared to the previous period [2] - The company's main business revenue composition includes 91.18% from waste resource utilization, with bio-based materials accounting for 79.60% of that [1]

Core Viewpoint - Fengbei Biotechnology Co., Ltd. has successfully listed on the Shanghai Stock Exchange, with a significant opening price increase and high trading volume, indicating strong market interest and investor confidence in the company [1]. Company Overview - Fengbei Biotechnology is a high-tech enterprise focused on the comprehensive utilization of waste resources, primarily producing resource-based products from waste oils [2]. - The controlling shareholder and actual controller of the company is Pingyuan, who directly holds 44.82% of the shares post-IPO and controls a total of 64.03% of the shares through indirect holdings [2]. Financial Performance - The company reported revenues of 170,869.32 million yuan, 172,778.32 million yuan, and 194,801.63 million yuan for the years 2022, 2023, and 2024 respectively, showing a steady growth trend [6]. - Net profits attributable to the parent company were 13,334.79 million yuan, 12,971.18 million yuan, and 12,381.99 million yuan for the same years, indicating a slight decline in profitability [6]. - For the first nine months of 2025, the company achieved revenues of 225,140.52 million yuan, a year-on-year increase of 62.32%, and a net profit of 11,729.88 million yuan, up 35.32% from the previous year [8][9]. IPO Details - The company issued 35.90 million new shares at an issue price of 24.49 yuan per share, raising a total of 879.191 million yuan, with a net amount of 794.438 million yuan after deducting issuance costs [4]. - The funds raised will be used for projects including the construction of production facilities for various bio-based products [4][5]. Future Outlook - The company plans to adjust its customer and product structure in 2024 while maintaining revenue growth, with a focus on managing sales and administrative expenses effectively [3]. - There are inquiries regarding the sustainability of revenue from biofuels and the growth potential of industrial-grade mixed oil sales, indicating a need for careful monitoring of market conditions and operational stability [3].

Market Overview - On November 5, A-shares and Hong Kong stocks opened significantly lower but gradually stabilized, with the Shanghai Composite Index rising 0.05% by midday after initially dropping nearly 1% [1][2] - The Hang Seng Index and the FTSE China A50 Index futures also showed resilience, with the latter up 0.14% after an initial drop of over 1% [6][8] Sector Performance - The power equipment sector led the gains in the A-share market, with multiple stocks hitting the daily limit up, including Jinpan Technology, Zhongzhi Technology, and Zhongneng Electric, all showing increases of around 20% [2][3] - The coal sector also performed well, with stocks like Antai Group and Baotailong hitting the daily limit up, and Dayou Energy showing an increase of over 8% [3][4] - The retail sector was strong, with Dongbai Group hitting the daily limit up, and other stocks like China Duty Free and Zhongbai Group also rising [4][5] New Listings - A new stock, Fengbei Biological, debuted on the A-share market, with its price surging over 210% during the trading session [11] - Fengbei Biological specializes in the comprehensive utilization of waste resources, particularly waste oils, and has developed a production chain for biofuels and bio-based materials [13][14]

Market Performance - On November 5, A-shares and Hong Kong stocks opened significantly lower but gradually stabilized, with the Shanghai Composite Index rising 0.05% by midday after initially dropping nearly 1% [3][8] - The A-share market saw over 3,000 stocks rise, while approximately 2,200 stocks declined, indicating a generally positive market sentiment despite initial losses [3][4] Sector Highlights - The power equipment sector led the gains in the A-share market, with stocks like Jinpan Technology, Zhongzhi Technology, and Zhongneng Electric hitting the daily limit of 20% [4][5] - Other notable performers included Fengyuan Co., Sun Cable, and Shunhua Electric, all of which also saw significant price increases [5][6] - The coal sector also showed strength, with stocks like Antai Group and Baotailong reaching their daily limit, and Dayou Energy experiencing a rise of over 8% [6] Hong Kong Market - The Hang Seng Index and the Hang Seng Tech Index saw their declines significantly narrow by midday, with the Hang Seng Index down 0.28% after an initial drop of over 1.7% [15] - Notable stocks in the Hang Seng Index included New Oriental and BYD, which were among the biggest decliners, while companies like Kang Shifu Holdings and WuXi AppTec led the gains [10][15] New Listings - A new stock, Fengbei Biological, debuted on November 5, with its price surging over 210% at one point during trading [12][14] - Fengbei Biological focuses on the comprehensive utilization of waste resources, particularly waste oils, and has established a strong technological foundation with numerous patents [14][16]

Core Viewpoint - N Fengbei (603334) debuted today with a significant opening increase of 169.50%, and by midday, the increase expanded to 185.91%, indicating strong market interest and trading activity [1] Company Overview - N Fengbei is a high-tech enterprise in the field of waste resource utilization, primarily focusing on the production of resource-based products from waste oils [1] - The company has developed a comprehensive industrial chain for waste resource recycling, which includes "waste oils - biofuels (biodiesel) - bio-based materials" [1] - N Fengbei leverages its core technology in oil fat utilization and channel advantages to provide oil fat chemicals to customers [1] Financial Highlights - The total number of shares issued in this IPO is 35.90 million, with an online issuance of 24.21 million shares at a price of 24.49 yuan per share [1] - The issuance price corresponds to a price-to-earnings (P/E) ratio of 30.47, significantly lower than the industry average P/E ratio of 64.73 [1] - The total funds raised from the IPO amount to 879 million yuan, which will be allocated to projects including the construction of a 300,000-ton annual production facility for methyl oleate, a 10,000-ton industrial-grade mixed oil facility, and other agricultural microbial agents and fertilizers [1]

Core Viewpoint - Company N Fengbei has successfully listed with an opening price of 66.00 yuan, reflecting a significant increase of 169.50% on its first trading day, indicating strong market interest and investor confidence in the company's business model and growth potential [2]. Company Overview - N Fengbei is a high-tech enterprise in the field of comprehensive utilization of waste resources, primarily focusing on the production of resource-based products from waste oils [2]. - The company has developed a production chain that includes waste oils, biodiesel, and bio-based materials, showcasing its commitment to sustainability and innovation in waste resource recycling [2]. Financial Performance - The total number of shares issued by the company is 35.90 million, with an online issuance of 24.21 million shares at a price of 24.49 yuan per share [2]. - The company's issuance price corresponds to a price-to-earnings (P/E) ratio of 30.47, which is significantly lower than the industry average P/E ratio of 64.73 [2]. - The total funds raised from the initial public offering (IPO) amount to 879 million yuan, which will be allocated to projects including the construction of a 300,000-ton annual production facility for methyl oleate, among others [2]. Recent IPO Performance - N Fengbei's first-day performance is part of a broader trend of newly listed stocks, with several companies experiencing substantial increases in their opening prices, indicating a robust market for IPOs in various sectors [3].

股票简称：丰倍生物 股票代码：603334 苏州丰倍生物科技股份有限公司 SUZHOU FENGBEI BIOTECH STOCK CO., LTD. （江苏扬子江国际化学工业园东海路 1 号） 首次公开发行股票主板上市公告书 保荐人（主承销商） （中国（上海）自由贸易试验区商城路 618 号） 二〇二五年十一月四日 苏州丰倍生物科技股份有限公司 上市公告书 特别提示 苏州丰倍生物科技股份有限公司（以下简称"丰倍生物""发行人""本公 司"或"公司"）股票将于 2025 年 11 月 5 日在上海证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在新 股上市初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 本上市公告书中若出现总数与各分项数值之和尾数不等的情况，均为四舍五 入尾差所致。 1 苏州丰倍生物科技股份有限公司 上市公告书 第一节 重要声明与提示 一、重要声明与提示 本公司及全体董事、监事、高级管理人员保证上市公告书所披露信息的真实、 准确、完整，承诺上市公告书不存在虚假记载、误导性陈述或者重大遗漏，并依 法承担法律责任。 上海证券交易所、有关政府机关对本公司股票上 ...